# A Study to Compare the Pharmacokinetics of CSL312 Administered by Prefilled Syringe Assembled to Autoinjector to the Pharmacokinetics Administered by Prefilled Syringe Assembled to Needle Safety Device in Healthy Subjects

> **NCT05306275** · PHASE1 · COMPLETED · sponsor: **CSL Behring** · enrollment: 132 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** CSL312

## Key facts

- **NCT ID:** NCT05306275
- **Lead sponsor:** CSL Behring
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-04
- **Primary completion:** 2022-09-27
- **Final completion:** 2022-09-27
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2022-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05306275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05306275, "A Study to Compare the Pharmacokinetics of CSL312 Administered by Prefilled Syringe Assembled to Autoinjector to the Pharmacokinetics Administered by Prefilled Syringe Assembled to Needle Safety Device in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05306275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*